by Ashley | Jul 15, 2020 | Press Release
San Diego based regenerative medicine company, Personalized Stem Cells, Inc. (PSC), has secured $2.5 million in a Series A round of financing led by seed investors and key opinion leaders in the field. The funds will enable PSC to complete the current FDA approved...
by Ashley | May 26, 2020 | Press Release
Personalized Stem Cells, Inc (PSC), a human adipose-derived stem cell company, has continued enrollment for participation in an FDA approved clinical trial for stem cell treatment of knee osteoarthritis. Though the trial never stopped, in-person visits were halted,...
by Ashley | May 22, 2020 | Blog, FDA Approved Clinical Trial, Stem Cell Therapy
Stem cells can differentiate into multiple tissue types such as bone, cartilage, muscle, and even cardiac and nerve tissues. They are sometimes called the “master cells” of the body. Literature demonstrates that stem cells have the ability to repair, regenerate, and...
by Ashley | May 20, 2020 | Press Release
The COVID-19 pandemic has taken our world by storm. Millions of people have contracted the virus with over 300,000 confirmed deaths. While self-isolation occurs across the globe, scientists and medical professionals are rushing to find safe and effective treatments to...
by Ashley | Apr 24, 2020 | Blog, COVID-19, Stem Cell Therapy
Personalized Stem Cells, Inc. (PSC) has filed a request for expedited review of an FDA Investigational New Drug (IND) for the treatment of COVID-19 patients with stem cells. The White House Coronavirus Task Force asked PSC to apply through the new FDA Coronavirus...